Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future.
Godman B, Egwuenu A, Wesangula E, Schellack N, Kalungia AC, Tiroyakgosi C, Kgatlwane J, Mwita JC, Patrick O, Niba LL, Amu AA, Oguntade RT, Alabi ME, Ncube NBQ, Sefah IA, Acolatse J, Incoom R, Guantai AN, Oluka M, Opanga S, Chikowe I, Khuluza F, Chiumia FK, Jana CE, Kalemeera F, Hango E, Fadare J, Ogunleye OO, Ebruke BE, Meyer JC, Massele A, Malande OO, Kibuule D, Kapona O, Zaranyika T, Bwakura-Dangarembizi M, Kujinga T, Saleem Z, Kurdi A, Shahwan M, Jairoun AA, Wale J, Brink AJ. Godman B, et al. Among authors: kalemeera f. Expert Opin Drug Saf. 2022 Aug;21(8):1089-1111. doi: 10.1080/14740338.2022.2106368. Epub 2022 Aug 30. Expert Opin Drug Saf. 2022. PMID: 35876080 Free article. Review.
Outcome of the first Medicines Utilization Research in Africa group meeting to promote sustainable and rational medicine use in Africa.
Massele A, Burger J, Katende-Kyenda NL, Kalemeera F, Kenaope T, Kibuule D, Mbachu O, Mubita M, Oluka M, Olusanya A, Paramadhas BD, van Zyl P, Godman B. Massele A, et al. Among authors: kalemeera f. Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):885-8. doi: 10.1586/14737167.2015.1088386. Epub 2015 Sep 14. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 26367814 Free article.
Outcome of the second Medicines Utilisation Research in Africa Group meeting to promote sustainable and appropriate medicine use in Africa.
Massele A, Burger J, Kalemeera F, Jande M, Didimalang T, Kalungia AC, Matshotyana K, Law M, Malone B, Ogunleye O, Oluka M, Paramadhas BD, Rwegerera G, Zinyowera S, Godman B. Massele A, et al. Among authors: kalemeera f. Expert Rev Pharmacoecon Outcomes Res. 2017 Apr;17(2):149-152. doi: 10.1080/14737167.2017.1256775. Epub 2016 Nov 18. Expert Rev Pharmacoecon Outcomes Res. 2017. PMID: 27809620 Free article.
Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa.
Ngambi PG, Kalungia AC, Law MR, Kalemeera F, Truter I, Godman B, Munkombwe D. Ngambi PG, et al. Among authors: kalemeera f. Expert Rev Pharmacoecon Outcomes Res. 2017 Oct;17(5):459-467. doi: 10.1080/14737167.2017.1364161. Epub 2017 Aug 11. Expert Rev Pharmacoecon Outcomes Res. 2017. PMID: 28770641 Free article. Review.
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.
Godman B, Bucsics A, Vella Bonanno P, Oortwijn W, Rothe CC, Ferrario A, Bosselli S, Hill A, Martin AP, Simoens S, Kurdi A, Gad M, Gulbinovič J, Timoney A, Bochenek T, Salem A, Hoxha I, Sauermann R, Massele A, Guerra AA Jr, Petrova G, Mitkova Z, Achniotou G, Laius O, Sermet C, Selke G, Kourafalos V, Yfantopoulos J, Magnusson E, Joppi R, Oluka M, Kwon HY, Jakupi A, Kalemeera F, Fadare JO, Melien O, Pomorski M, Wladysiuk M, Marković-Peković V, Mardare I, Meshkov D, Novakovic T, Fürst J, Tomek D, Zara C, Diogene E, Meyer JC, Malmström R, Wettermark B, Matsebula Z, Campbell S, Haycox A. Godman B, et al. Among authors: kalemeera f. Front Public Health. 2018 Dec 5;6:328. doi: 10.3389/fpubh.2018.00328. eCollection 2018. Front Public Health. 2018. PMID: 30568938 Free PMC article. Review.
Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries.
Godman B, Grobler C, Van-De-Lisle M, Wale J, Barbosa WB, Massele A, Opondo P, Petrova G, Tachkov K, Sefah I, Abdulsalim S, Alrasheedy AA, Unnikrishnan MK, Garuoliene K, Bamitale K, Kibuule D, Kalemeera F, Fadare J, Khan TA, Hussain S, Bochenek T, Kalungia AC, Mwanza J, Martin AP, Hill R, Barbui C. Godman B, et al. Among authors: kalemeera f. Expert Opin Pharmacother. 2019 Dec;20(18):2237-2255. doi: 10.1080/14656566.2019.1684473. Expert Opin Pharmacother. 2019. PMID: 31762343 Free article. Review.
31 results